Vandetanib plus gemcitabine versus placebo plus gemcitabine in locally advanced or metastatic pancreatic carcinoma (ViP): a prospective, randomised, double-blind, multicentre phase 2 trial
Titel:
Vandetanib plus gemcitabine versus placebo plus gemcitabine in locally advanced or metastatic pancreatic carcinoma (ViP): a prospective, randomised, double-blind, multicentre phase 2 trial
Auteur:
Middleton, Gary Palmer, Daniel H Greenhalf, William Ghaneh, Paula Jackson, Richard Cox, Trevor Evans, Anthony Shaw, Victoria E Wadsley, Jonathan Valle, Juan W Propper, David Wasan, Harpreet Falk, Stephen Cunningham, David Coxon, Fareeda Ross, Paul Madhusudan, Srinivasan Wadd, Nick Corrie, Pippa Hickish, Tamas Costello, Eithne Campbell, Fiona Rawcliffe, Charlotte Neoptolemos, John P